Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Myocardial Infarction And Subarachnoid Hemorrhage. Frequency And Impact On Outcome
Cerebrovascular Disease and Interventional Neurology
Cerebrovascular Disease and Interventional Neurology Posters (7:00 AM-5:00 PM)
100
Subarachnoid hemorrhage is known to be associated with systemic complications including neurogenic pulmonary edema and Talkotsubo cardiomyopathy. We set to establish the frequency of myocardial infarction (MI) and its impact on outcome among patients with subarachnoid hemorrhage
NA
 We analyzed the data from Nationwide Inpatient Sample (2005-2014) for all subarachnoid hemorrhage (ICH) patients. Myocardial infraction (MI) was identified using the International Classification of Disease, 9th Revision, Clinical Modification codes. Baseline characteristics, discharge outcomes (mortality, moderate to severe disability at dischagre, length of stay and in-hospital charges) were compared between the two groups
Of the 325923 patients with SAH, 12720 (3.90%) had in-hospital myocardial infraction. SAH
patients with MI were older (64.6 years versus 59.0 years, P <.0001) compared to SAH patients without MI but
there was no difference in-term of proportion of females between the two groups. The in-hospital mortality was
also higher (49.8% versus 23.9%, p≤.0001) among patients with MI in both univariate and multivariate analysis (OR
= 1.75 (1.59 -1.93), P<.0001) after adjusting for potential confounders. SAH patients with MI had higher (68.5%
versus 40.9%, P <.0001) proportion of moderate to severe disability at discharge compared to ones without.
Similarly, mean length of in-hospital stay (13.2 days versus 11.8 days, P <.0001) and mean hospital charges
($188845 versus $150062, P <.0001) were also higher in SAH patients with MI
While MI was reported in only 3.9% of SAH cases it had a significant impact on outcome with a one fold increase in morality and about 75% increase risk of severe disability.
Authors/Disclosures
Baljinder Singh, MD
PRESENTER 		Dr. Singh has nothing to disclose.
Hussan Gill Mr. Gill has nothing to disclose.
Mohammad Rauf A. Chaudhry, MD Dr. Chaudhry has nothing to disclose.
Saqib A. Chaudhry, MD Dr. Chaudhry has nothing to disclose.
Harathi Bandaru, MD Dr. Bandaru has nothing to disclose.
Mohammad Ghatali, MD (Texas Tech Health Science Center) Dr. Ghatali has nothing to disclose.
Sushma R. Yerram, MD (Texas tech University of Health Sciences) Dr. Yerram has nothing to disclose.
Anantha Vellipuram, MD Dr. Vellipuram has nothing to disclose.
Paisith Piriyawat, MD (Texas Tech University) Dr. Piriyawat has nothing to disclose.
Alberto Maud, MD (Paul L. Foster School of Medicine Texas Tech UHSC El Paso, Texas) Dr. Maud has nothing to disclose.
Gustavo J. Rodriguez, MD (Gustavo J. Rodriguez) Dr. Rodriguez has nothing to disclose.
Salvador Cruz-Flores, MD, FÂ鶹´«Ã½Ó³»­ (Paul L. Foster School of Medicine Texas Tech University Health Sciences Center) The institution of Dr. Cruz-Flores has received research support from University of Texas System.